BR112013011418A8 - derivado de pirazino [2,3-d] isoxadol - Google Patents

derivado de pirazino [2,3-d] isoxadol

Info

Publication number
BR112013011418A8
BR112013011418A8 BR112013011418A BR112013011418A BR112013011418A8 BR 112013011418 A8 BR112013011418 A8 BR 112013011418A8 BR 112013011418 A BR112013011418 A BR 112013011418A BR 112013011418 A BR112013011418 A BR 112013011418A BR 112013011418 A8 BR112013011418 A8 BR 112013011418A8
Authority
BR
Brazil
Prior art keywords
isoxadol
pyrazine
derivative
isoxadol derivative
Prior art date
Application number
BR112013011418A
Other languages
English (en)
Other versions
BR112013011418B1 (pt
BR112013011418A2 (pt
Inventor
Naitou Hiroyuki
Watanabe Katsuyuki
Nakamura Kouki
Hanaki Naoyuki
Murakami Takeshi
Original Assignee
Fujifilm Corp
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp, Toyama Chemical Co Ltd filed Critical Fujifilm Corp
Publication of BR112013011418A2 publication Critical patent/BR112013011418A2/pt
Publication of BR112013011418A8 publication Critical patent/BR112013011418A8/pt
Publication of BR112013011418B1 publication Critical patent/BR112013011418B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08Hydroxylamino compounds or their ethers or esters
    • C07C239/18Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32Oximes
    • C07C251/34Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/36Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/38Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/23Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same unsaturated acyclic carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/24Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
    • C07C255/29Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups and acylated amino groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR112013011418-5A 2010-11-12 2011-11-11 Derivado de pirazino[2,3-d]isoxazol, métodos para a produção de um derivado de pirazino [2,3-d]isoxazol e compostos BR112013011418B1 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2010-253414 2010-11-12
JP2010253414 2010-11-12
JP2010-256510 2010-11-17
JP2010256510 2010-11-17
JP2011-025760 2011-02-09
JP2011025760 2011-02-09
PCT/JP2011/076029 WO2012063931A1 (ja) 2010-11-12 2011-11-11 ピラジノ〔2,3-d〕イソオキサゾール誘導体

Publications (3)

Publication Number Publication Date
BR112013011418A2 BR112013011418A2 (pt) 2016-07-19
BR112013011418A8 true BR112013011418A8 (pt) 2018-08-14
BR112013011418B1 BR112013011418B1 (pt) 2021-03-16

Family

ID=46051068

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013011418-5A BR112013011418B1 (pt) 2010-11-12 2011-11-11 Derivado de pirazino[2,3-d]isoxazol, métodos para a produção de um derivado de pirazino [2,3-d]isoxazol e compostos

Country Status (18)

Country Link
US (2) US8901302B2 (pt)
EP (1) EP2639235B1 (pt)
JP (1) JP5787727B2 (pt)
KR (1) KR101902857B1 (pt)
CN (1) CN103347884B (pt)
AU (1) AU2011327111B2 (pt)
BR (1) BR112013011418B1 (pt)
CA (1) CA2816687C (pt)
ES (1) ES2535341T3 (pt)
HK (1) HK1185882A1 (pt)
IL (1) IL226228A (pt)
MX (1) MX2013005179A (pt)
NZ (1) NZ611498A (pt)
RU (1) RU2570802C2 (pt)
SG (1) SG190772A1 (pt)
TW (1) TWI486350B (pt)
WO (1) WO2012063931A1 (pt)
ZA (1) ZA201304074B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104817511B (zh) * 2015-04-27 2017-04-19 济南大学 一种丁烯二酸酐制备法匹拉韦关键中间体的方法
CN113735784A (zh) * 2020-05-28 2021-12-03 南京桦冠生物技术有限公司 6-氟-3-羟基吡嗪-2-甲酰胺的制备方法
CN114478404A (zh) * 2022-03-17 2022-05-13 浙江海正药业股份有限公司 一种法维拉韦中间体羟基物的纯化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ282939B6 (cs) * 1992-03-04 1997-11-12 Lonza A.G. Mikrobiologický způsob hydroxylace dusíkatých heterocyklických karboxylových kyselin
TW394760B (en) * 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
DE69937405T2 (de) * 1998-08-20 2008-02-14 Toyama Chemical Co. Ltd. Stickstoffheterocyclische Carboxamidverbindungen oder deren Salze als antivirale Mittel
JP4379767B2 (ja) 2000-02-16 2009-12-09 富山化学工業株式会社 新規なピラジン誘導体またはその塩、それらを含有する医薬組成物並びにそれらの製造中間体
KR101574567B1 (ko) 2007-09-27 2015-12-07 토야마 케미칼 컴퍼니 리미티드 6-플루오로-3-히드록시-2-피라진카보니트릴의 유기아민염 및 그 제조법
JP5364327B2 (ja) * 2008-09-26 2013-12-11 富士フイルム株式会社 ハロピラジンカルボキサミド化合物の製造方法

Also Published As

Publication number Publication date
AU2011327111B2 (en) 2015-04-23
JP2012180336A (ja) 2012-09-20
IL226228A0 (en) 2013-07-31
US20150051396A1 (en) 2015-02-19
KR20140082588A (ko) 2014-07-02
CN103347884B (zh) 2015-12-02
JP5787727B2 (ja) 2015-09-30
NZ611498A (en) 2014-05-30
WO2012063931A1 (ja) 2012-05-18
CA2816687A1 (en) 2012-05-18
RU2013126415A (ru) 2014-12-20
KR101902857B1 (ko) 2018-10-01
EP2639235A4 (en) 2014-07-30
TW201226412A (en) 2012-07-01
RU2570802C2 (ru) 2015-12-10
EP2639235B1 (en) 2015-04-08
HK1185882A1 (en) 2014-02-28
IL226228A (en) 2017-11-30
BR112013011418B1 (pt) 2021-03-16
US8901302B2 (en) 2014-12-02
SG190772A1 (en) 2013-08-30
US20130245264A1 (en) 2013-09-19
AU2011327111A1 (en) 2013-05-02
CA2816687C (en) 2018-11-27
EP2639235A1 (en) 2013-09-18
MX2013005179A (es) 2013-07-05
ES2535341T3 (es) 2015-05-08
TWI486350B (zh) 2015-06-01
BR112013011418A2 (pt) 2016-07-19
US9181203B2 (en) 2015-11-10
ZA201304074B (en) 2014-08-27
CN103347884A (zh) 2013-10-09

Similar Documents

Publication Publication Date Title
FR17C1040I2 (fr) Derive antiviraux de 2,5-dibenzimidazol-5-yl-1-phenyl-pyrrolidine
ZA201205788B (en) 1,2,4-triazine-4-amine derivatives
EP2762476A4 (en) 1,2,4-triazine-6-carboxamide derivative
BR112012028519A2 (pt) compostos de 2,5,6,7-tetrahidro-[1,4]oxazepin-3-ilamina ou 2,3,6,7-tetrahidro-[1,4]oxazepin-5-ilamina
ZA201206630B (en) Hetaryl-[1,8]naphthyridine derivatives
HK1198586A1 (zh) -二氟甲基- -二氫- 噁嗪- -胺衍生物
HK1192757A1 (zh) 取代的 -芳基- -苯基- -三嗪- -胺
RS55579B1 (sr) Novi pirazinski derivati
EP2727920A4 (en) DERIVED FROM 1,5-NAPHTHYRIDINE OR SALT THEREOF
SMT201500166B (it) Derivato di 1,2,4-triazolone
EP2851075A4 (en) PREPARATION WITH 6,7-UNSATED 7-CARBAMOYLMORPHINANE DERIVATIVE
BR112013011418A8 (pt) derivado de pirazino [2,3-d] isoxadol
HK1206727A1 (en) Pyrazine derivatives
HK1188717A1 (zh) 種抗病毒 -苯基- -二苯並咪唑- -基-吡咯烷衍生物
AU2011904403A0 (en) The Ducks foot
EP2865747A4 (en) 4,6-HEXADECADIENE-2,4-DICARBOXYLIC ACID DERIVATIVE
AU2012904701A0 (en) Supramolecular Structure
TH148776B (th) ออกซี-ไซโคลเฮกซิล-4H,6H-5-ออกซา-2,3,10b-ไตรอะซา-เบนโซ[e]อะซูลีนในรูปสารต้าน V1a
AU2010902769A0 (en) Garment

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: FUJIFILM TOYAMA CHEMICAL CO., LTD. (JP)

B25A Requested transfer of rights approved

Owner name: FUJIFILM TOYAMA CHEMICAL CO., LTD. (JP)

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/11/2011, OBSERVADAS AS CONDICOES LEGAIS.